09 August 2004
GlaxoSmithKline plc (the "Company") announces that in accordance with the
authority granted by shareholders at the Company's Annual General Meeting on 17
May 2004 it purchased 750,000 of it's Ordinary shares of 25 pence each ("shares
") on 9 August 2004 at a price of 1060.03 pence per share.
The Company intends to hold these shares in Treasury.
Following the purchase of these shares, the Company holds 31,718,000 of it's
shares in Treasury and has 5,902,323,254 shares in issue (excluding Treasury
This announcement does not constitute, or form part of, an offer or any
solicitation of an offer to purchase or subscribe for securities in any
This information is provided by RNS
The company news service from the London Stock Exchange